Free Trial
NASDAQ:LEXXW

Lexaria Bioscience (LEXXW) Stock Price, News & Analysis

$0.59 -0.06 (-9.69%)
As of 01/14/2025 03:59 PM Eastern

About Lexaria Bioscience Stock (NASDAQ:LEXXW)

Key Stats

Today's Range
$0.55
$0.63
50-Day Range
$0.59
$0.89
52-Week Range
$0.45
$2.50
Volume
17,331 shs
Average Volume
7,729 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Receive LEXXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

LEXXW Stock News Headlines

Lexaria Bioscience Earnings Analysis: Q1 Recap
Lexaria Bioscience finalizes clinical study agreement
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.
LEXX: Phase I Start Imminent
Lexaria Bioscience’s DehydraTECH Outshines in Diabetes Study
See More Headlines

LEXXW Stock Analysis - Frequently Asked Questions

Lexaria Bioscience's stock was trading at $0.7641 at the beginning of the year. Since then, LEXXW stock has decreased by 23.2% and is now trading at $0.5870.
View the best growth stocks for 2025 here
.

Shares of LEXXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LEXXW
Web
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$464,278.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:LEXXW) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners